News

Find News

Filter articles

Showing 141 to 150 of 3629 results

NextCure targeted in cancer drug trade secrets suit

US16-12-2021Alex Baldwin

Public biopharmaceutical company NextCure has been accused of misappropriating trade secrets in order to create a direct competitor to a biotech’s cancer immunotherapy technology.

Gilead, BMS, Janssen facing HIV generic antitrust suit

US16-12-2021Muireann Bolger

Gilead, Bristol-Myers Squibb and Janssen are facing accusations that they suppressed competition in the market for drugs used to treat the human immunodeficiency virus.

Intubated patients sedative patent the focus of ACS Dobfar suit

US16-12-2021Alex Baldwin

Sun Pharmaceutical has been sued by ACS Dobfar subsidiary InfoRLife and WG Critical Care for allegedly infringing on a patent with its proposed midazolam-an anaesthesia medication.

3M stumbles in litigation strategy over COVID-19 masks

US14-12-2021Muireann Bolger

Multinational 3M has suffered a setback in its litigation campaign against the distributors of N95 masks after a US judge found in favour of arguments made by one of its opponents.

Generics win anti-pay-for-delay bill challenge

US14-12-2021Alex Baldwin

The Association for Accessible Medicines, which represents manufacturers of generics and biosimilars, has succeeded in challenging a California bill that characterises “reverse payment” or “pay-for-delay” patent settlements as anticompetitive and unlawful.

Pharmavite accuses Bausch, GSK of ‘sham’ patent litigation

US13-12-2021Alex Baldwin

Nutritional supplements manufacturer Pharmavite has filed an antitrust suit against Bausch & Lomb and GlaxoSmithKline, claiming that they are filing sham patent litigation related to its “PreserVision” products.

GSK responds to Teva’s ‘skinny’ label rehearing petition

US09-12-2021Alex Baldwin

Following a substantial push from generics companies to reverse the GSK v Teva “skinny” label ruling, GlaxoSmithKilne has added its response to the petition to rehear the case yet again.

Teva loses appeal to invalidate Korlym patent

US09-12-2021Alex Baldwin

Teva Pharmaceuticals has failed to convince the US Court of Appeal for the Federal Circuit that a Corcept Therapeutics method patent for Korlym was invalid.

Mylan gets Fed Circ reprieve in inhaler dispute

US09-12-2021Muireann Bolger

Mylan has been allowed to revisit a decision holding that it infringed patents covering AstraZeneca's inhaler asthma treatment, Symbicort.

Fresenius in patent dispute over hypocalcemia treatment

US07-12-2021Muireann Bolger

Fresenius Kabi is facing a lawsuit by two Pharmasphere subsidiaries over claims that it infringed a patent covering a treatment for hypocalcemia, a condition where the blood sugar level is lower than normal.

Showing 141 to 150 of 3629 results

LSIPR